re: Ann: JP Morgan Healthcare Conference Pres... This investor preview article gives a sense of how important the conference is, as the 'oldest, largest and most important healthcare conference' even if PRR is currently still a tiddler.
http://www.thestreet.com/story/10962460/1/biotechs-2011-kickoff-party-investor-preview.html
In another link I was vaguely interested to note that PRR is one of the 99 cancer investigators listed by name (in table 183) of 'Commercialising Cancer Vaccines: A decision Support Tool for Optimising the Pipeline.' (Don't bother Googling it, - costs $2730 and is for optimising the commercialisation of cancer vaccines, not optimising bio-investment decisions.)
Ann: JP Morgan Healthcare Conference Presentation, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.015(5.08%) |
Mkt cap ! $453.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.3¢ | 30.0¢ | $777.0K | 2.521M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 431924 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 154861 | 9 |
View Market Depth
| Last trade - 14.16pm 23/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |